HODGKIN'S DISEASE MIXED CELLULARITY STAGE IV

HODGKIN'S DISEASE MIXED CELLULARITY STAGE IV was reported 4 times

HODGKIN'S DISEASE MIXED CELLULARITY STAGE IV is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Topoisomerase Inhibitor [EPC] 1 0.0000
1 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
2 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
3 Alkylating Drug [EPC] 1 0.0000
4 Platinum-based Drug [EPC] 1 0.0000
5 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
6 Vitamin D [EPC] 1 0.0000
7 Vitamin B12 [EPC] 1 0.0000
8 Tumor Necrosis Factor Blocker [EPC] 3 0.0000
9 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
10 Vitamin C [EPC] 1 0.0000